Antibody Therapeutics Patients First!

공지사항


번호 제목 작성자 작성일 조회
13   Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm in Seoul on June 23, 2017.   관리자   2018-08-06   25  
12   Dr. Jin-San Yoo, CEO of PharmAbcine is presenting PharmAbcine`s R&D progress and the interim data of the ongoing phase IIa recurrent GBM trial at 2017 Bio International Convention in San Diego on June 19-22, 2017.   관리자   2018-08-06   39  
11   Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM trial in Australia expose the interim data of the ongoing trial at ASCO 2017 Annual Meeting in Chicago on June 2-6, 2017.]   관리자   2018-08-06   34  
10   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at BIO LOGISTICS WORLD KOREA in Seoul on May 23-24, 2017.   관리자   2018-08-06   30  
9   Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an expert of MAB working group of EDQM observer representing Republic of Korea.   관리자   2018-08-06   28  
8   Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an officer for Bio at the Med term Strategy and planning for pharma industry.]   관리자   2018-08-06   33  
7   Dr. Jin-San Yoo, CEO of PharmAbcine will be awarded for the contribution of Health-Medical by KHIDI President on April 13th, 2017.   관리자   2018-08-06   35  
6   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present at ``BizForum`` at BioKorea 2017.   관리자   2018-08-06   30  
5   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present at ``HI KOREA INVEST FAIR 2017``   관리자   2018-08-06   29  
4   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present at BioPharm Asia in Singapore on March 21st-23rd, 2017.   관리자   2018-08-06   29